Expression of the hepatocyte growth factor and c-Met in colon cancer: Correlation with clinicopathological features and overall survival

Tumori

Volumn 98, Issue 1, 2012, Pages 105-112

  Liu, Yao ^a   Li, Qiaoyan ^b   Zhu, Liwei ^c  

^a CAPITAL INSTITUTE OF PEDIATRICS   (China)

^b TIANJIN FIRST CENTRAL HOSPITAL   (China)

^c TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

c Met; Colon cancer; Expression; HGF; Prognosis

Indexed keywords

MESSENGER RNA; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; TUMOR MARKER; COMPLEMENTARY DNA;

ADULT; AGED; ARTICLE; C MET GENE; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; COLON CARCINOMA; CONTROLLED STUDY; FEMALE; GENE; GENE OVEREXPRESSION; HCF GENE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SURVIVAL TIME; ASIAN; CHEMISTRY; CHINA; COLON TUMOR; GENE EXPRESSION REGULATION; GENETICS; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PATHOLOGY; PREDICTIVE VALUE; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; STATISTICS; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; COLONIC NEOPLASMS; DNA, COMPLEMENTARY; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATOCYTE GROWTH FACTOR; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROTO-ONCOGENE PROTEINS C-MET; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; UP-REGULATION;

EID: 84863204524     PISSN: 03008916     EISSN: 20382529     Source Type: Journal    
DOI: 10.1177/030089161209800115     Document Type: Article

References (23)

1. Jass JR, Young J, Leggett BA: Evolution of colorectal cancer: change of pace and change of direction. J Gastroenterol Hepatol, 17: 17-26, 2002. (Pubitemid 34304382)
2. Wang L, Cheng H, Liu Y, Wang L, Yu W, Zhang G, Chen B, Yu Z, Hu S: Prognostic value of nuclear β-catenin overexpression at invasive front in colorectal cancer for synchronous liver metastasis. Ann Surg Oncol, 18: 1553-1559, 2011.
3. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM, Bos JL: Genetic alterations during colorectal-tumor development. N Engl J Med, 319: 525-532,1988.
4. Hiscox SE, Hallett MB, Puntis MC, Nakamura T, Jiang WG: Expression of the HGF/SF receptor, c-met, and its ligand in human colorectal cancers. Cancer Invest, 15: 513-521, 1997. (Pubitemid 28015594)
5. Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF: Met, metastasis, motility and more. Nat Rev Mol Cell Biol, 4: 915-925, 2003. (Pubitemid 37493640)
6. Baykal C, Ayhan A, Al A, Yüce K, Ayhan A: Overexpression of the c-Met/HGF receptor and its prognostic significance in uterine cervix carcinomas. Gynecol Oncol, 88: 123-129, 2003. (Pubitemid 36263369)
7. Huang TJ, Wang JY, Lin SR, Lian ST, Hsieh JS: Overexpression of the c-met protooncogene in human gastric carcinoma. Acta Oncol, 40: 638-643, 2001.
8. Beviglia L, Matsumoto K, Lin CS, Ziober BL, Kramer RH: Expression of the c-met/HGF receptor in human breast carcinoma: correlation with tumor progression. Int J Cancer, 74: 301-309, 1997. (Pubitemid 27321800)
9. Yu J, Ohuchida K, Mizumoto K, Ishikawa N, Ogura Y, Yamada D, Egami T, Fujita H, Ohashi S, Nagai E, Tanaka M: Overexperssion of c-met in the early stage of pancreatic carcinogenesis; altered expression is not sufficient for progression from chronic pancreatitis to pancreatic cancer. Word J Gastroenterol, 12: 3878-882, 2006. (Pubitemid 44028401)
10. Otte JM, Schmitz F, Kiehne K, Stechele HU, Banasiewicz T, Krokowicz P, Nakamura T, Fölsch UR, Herzig K: Functional expression of HGF and its receptor in human colorectal cancer. Digestion, 61: 237-246, 2000. (Pubitemid 30418224)
11. Fukuura T, Miki C, Inoue T, Matsumoto K, Suzuki H: Serum hepatocyte growth factor as an index of disease status of patients with colorectal carcinoma. Br J Cancer, 78: 454-459, 1998. (Pubitemid 28360631)
12. Zeng Z, Weiser MR, D'Alessio M, Grace A, Shia J, Paty PB: Immunoblot analysis of c-Met expression in human colorectal cancer: Overexpression is associated with advanced stage cancer. Clin Exp Metastasis, 21: 409-417, 2004.
13. Di Renzo MF, Olivero M, Giacomini A, Porte H, Chastre E, Mirossay L, Nordlinger B, Bretti S, Bottardi S, Giordano S: Overexpression and smplification of the Met/HGF receptor gene during the progression of colorectal cancer. Clin Cancer Res, 1: 147-154,1995.
14. Topcu-Yilmaz P, Kiratli H, Saglam A, Soylemezoglu F, Hascelik G: Correlation of clinicopathological parameters with HGF, c-Met, EGFR, and IGF-1R expression in uveal melanoma. Melanoma Res, 20: 126-132, 2010.
15. Takeuchi H, Bilchik A, Saha S, Turner R, Wiese D, Tanaka M, Kuo C, Wang HJ, Hoon DS: c-MET expression level in primary colon cancer: a predictor of tumor invasion and lymph node metastases. Clin Cancer Res, 9: 1480-1488, 2003. (Pubitemid 36418405)
16. Edge SB, Compton CC: The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol, 17: 1471-1474, 2010.
17. Trusolino L, Comoglio PM: Scatter-factor and semaphoring receptors: cell signaling for invasive growth. Nat Rev Cancer, 2: 289-300, 2002. (Pubitemid 37328782)
18. Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF: Met, metastasis, motility and more, Nat Rev Mol Cell Biol, 4: 915-925, 2003. (Pubitemid 37493640)
19. Baldus SE, Kort EJ, Schirmacher P, Dienes HP, Resau JH: Quantification of MET and hepatocyte growth factor/scatter factor expression in colorectal adenomas, carcinomas and nonneoplastic epithelia by quantitative laser scanning microscopy. Int J Oncol, 31: 199-204, 2007.
20. Bardi G, Johansson B, Pandis N, Bak-Jensen E, Orndal C, Heim S, Mandahl N, Andrén-Sandberg A, Mitelman F: Cytogenetic aberrations in colorectal adenocarcinomas and their correlation with clinicopathobogic features. Cancer, 71: 306-314, 1993. (Pubitemid 23021213)
21. Saccone S, Narsimhan RP, Gaudino G, Dalprà L, Comoglio PM, Della Valle G: Regional mapping of the human hepatocyte growth factor (HGF)-scatter factor to chromosome 7q21.1. Genomics, 13: 912-914, 1992.
22. Ginty F, Adak S, Can A, Gerdes M, Larsen M, Cline H, Filkins R, Pang Z, Li Q, Montalto MC: The relative distribution of membranous and cytoplasmic met is a prognostic indicator in stage I and II colon cancer. Clin Cancer Res, 14: 3814-3822, 2008.
23. Resnick MB, Routhier J, Konkin T, Sabo E, Pricolo VE: Epidermal growth factor receptor, c-MET, beta-catenin, and p53 expression as prognostic indicators in stage II colon cancer: A tissue microarray study. Clin Cancer Res, 10: 3069-3075, 2004. (Pubitemid 38619685)